Evidence map›Paper›PMID 41479013›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Methods for Probing NK Cell Surveillance of Antigen Presentation.

Kamila Król, Doriana Fruci

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kamila KrólBambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Doriana FruciBambino Gesù Children's Hospital, IRCCS, Rome, Italy. doriana.fruci@opbg.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer (NK) cells are critical components of the innate immune system, capable of rapidly identifying and eliminating virus-infected and tumor cells without prior antigen sensitization. This rapid cytotoxic response is regulated by a balance between activating and inhibitory receptor signals, a mechanism known as "missing self." Inhibitory receptors recognize HLA class I molecules, preventing unwanted activation against healthy cells, while activating receptors detect stress-induced ligands on abnormal cells, triggering the release of perforin and granzyme B.Recent evidence shows that inhibitory receptor-HLA class I interactions are peptide-dependent, highlighting a complexity similar to T cell receptor recognition. Alterations in the antigen processing and presentation pathway in cancer cells can modify the immunopeptidome, enhancing NK-mediated cytotoxicity.To assess NK cell function and receptor-ligand interactions, degranulation and killing assays are widely employed. These methods are applicable to both primary NK cells and established NK cell lines, which differ in receptor expression and cytotoxic capabilities. Strategic selection of NK models and target systems allows for in-depth studies of NK cell biology and supports the development of NK cell-based immunotherapies.

Indexed as

Antigen PresentationImmunologic SurveillanceKiller Cells, NaturalCell DegranulationCytotoxicity, ImmunologicFlow CytometryGranzymesHistocompatibility Antigens Class IHumansPerforinGranzymesHistocompatibility Antigens Class IPerforinAntigen presentationAntigen probingCytotoxicityDegranulation assayFlow cytometryHLA class IImmunotherapyKilling assayNK cells

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.